ACADIA PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Acadia Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $31.6M.
  • Acadia Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $112M.
  • Acadia Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$73.4M, a 67.2% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$224M, a 31.2% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$170M, a 40.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $112M $31.6M +$89.4M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $22.8M $30.4M +$27.4M +902% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$4.59M $15.2M +$68.8M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$73.4M $34.9M +$81M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$154M -$57.8M -$26.9M -87.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$127M $3.04M +$36.7M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$164M -$53.6M +$59.4M +52.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$224M -$46.1M -$1.41M -3.15% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$222M -$30.9M -$15.6M -102% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$207M -$33.7M +$10.1M +23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$217M -$113M -$46.2M -69.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$170M -$44.7M +$22.5M +33.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$193M -$15.3M +$70.6M +82.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$264M -$43.7M +$301K +0.68% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$264M -$66.8M +$22.7M +25.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$287M -$67.2M -$10.8M -19.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$276M -$85.9M -$40.5M -89.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$235M -$44M +$13.1M +22.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$248M -$89.5M -$1.88M -2.15% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$247M -$56.4M +$10.9M +16.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$257M -$45.4M +$15.9M +25.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$273M -$57.1M +$6.99M +10.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$280M -$87.6M -$32.8M -59.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$247M -$67.3M +$2.73M +3.91% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$250M -$61.3M +$4.37M +6.66% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 -$255M -$64.1M +$3.96M +5.82% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$259M -$54.8M +$33.9M +38.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$292M -$70M +$8.22M +10.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$301M -$65.6M +$6.76M +9.33% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$307M -$68M +$3.89M +5.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$311M -$88.7M -$38.5M -76.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$273M -$78.2M -$32.7M -71.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$240M -$72.4M -$33.4M -85.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$207M -$71.9M -$32.4M -82.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$174M -$50.3M -$9.71M -23.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$165M -$45.6M -$17M -59.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$148M -$39M -$14M -56% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$134M -$39.5M -$17.8M -81.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$116M -$40.6M -$22.6M -126% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$93.2M -$28.6M -$16.4M -135% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$76.8M -$25M -$14.2M -131% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$62.7M -$21.7M -$12.6M -137% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$50.1M -$18M -$11.8M -191% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$38.3M -$12.2M -$5.35M -78.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$33M -$10.8M -$8.4M -349% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$24.5M -$9.16M -$3.73M -68.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$20.8M -$6.16M +$67K +1.08% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q4 2012 -$20.9M -$6.82M -$1.51M -28.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 -$19.4M -$2.41M +$2.69M +52.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 -$22.1M -$5.43M +$1.16M +17.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$23.2M -$6.23M -$370K -6.31% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 -$22.9M -$5.31M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 -$5.09M -$851K -20.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$6.58M -$2.29M -53.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$5.86M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q3 2010 -$4.24M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$4.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.